Table 1.
Attrition rates by demographic and clinical characteristics among clients living with HIV and enrolled for care in Maputo, Mozambique, 2009–2011
| Category | Subcategory | Number (%) | Attrition rate per 100 PY | (95% CI) |
|---|---|---|---|---|
| Total | – | 1,657 (100) | 28 | (26–30) |
| Sex | Male | 847 (51) | 32 | (29–36) |
| Female | 808 (49) | 24 | (22–27) | |
| Unknown | 2 (0) | 29 | (4–208) | |
| Age (years) | <25 | 143 (9) | 30 | (24–38) |
| 25–34 | 730 (44) | 28 | (25–31) | |
| 35–44 | 414 (25) | 25 | (22–30) | |
| ≥45 | 361 (22) | 32 | (28–37) | |
| Unknown | 9 (1) | 21 | (8–57) | |
| Kaposi sarcoma | Yes | 314 (19) | 41 | (35–48) |
| No | 1,343 (81) | 27 | (25–29) | |
| WHO stage | 1 | 249 (15) | 19 | (15–24) |
| 2 | 257 (16) | 17 | (14–21) | |
| 3 | 557 (34) | 25 | (22–28) | |
| 4 | 584 (35) | 46 | (41–51) | |
| Not recorded | 10 (1) | 29 | (12–71) | |
| CD4 count | <50 | 346 (21) | 15 | (12–17) |
| 50–249 | 40 (2) | 14 | (8–25) | |
| 250–349 | 13 (1) | 34 | (17–69) | |
| >350 | 16 (1) | 25 | (13–49) | |
| Unknown | 1,242 (75) | 36 | (33–39) | |
| BMI (kg/m2) | <16 | 186 (11) | 45 | (38–54) |
| 16–18.5 | 334 (20) | 30 | (26–35) | |
| ≥18.5 | 939 (57) | 21 | (19–23) | |
| Unknown | 198 (12) | 61 | (52–73) | |
| ART status at the time of presentation | Yes | 247 (15) | 627 | (553–712) |
| No | 1,410 (85) | 20 | (19–22) | |
| ART regimen* | First-line | 1,356 (96) | 20 | (19–22) |
| Second-line | 54 (4) | 17 | (10–27) | |
| Year of admission | 2009 | 590 (36) | 19 | (17–21) |
| 2010 | 407 (25) | 28 | (24–33) | |
| 2011 | 660 (40) | 47 | (42–53) |
100 PYs, 100 person-years of observation; CI, confidence interval; WHO, World Health Organization; BMI, body mass index; ART, antiretroviral therapy.
*
Only for those in whom ART was initiated at the study site and information was available.